summari
total
clinic
ill
cat
previous
diagnos
felin
infecti
periton
fip
treat
combin
recombin
felin
interferon
glucocorticoid
complet
remiss
year
partial
remiss
month
observ
four
four
case
respect
surviv
year
older
cat
year
old
effus
form
fip
esfm
aafp
publish
elsevi
ltd
right
reserv
felin
infecti
periton
fip
felin
coronaviru
fcov
diseas
recogn
worldwid
consid
fatal
diseas
speci
rohrbach
et
al
gener
accept
therapi
includ
glucocorticoid
without
immunosuppress
agent
cyclophosphamid
mcreynold
maci
document
therapi
includ
use
human
interferon
propionibacterium
acn
prepar
weiss
et
al
ozagrel
hydrochlorid
watari
et
al
complet
resolut
diseas
report
clinic
diagnosi
fip
practic
set
challeng
practition
date
singl
antemortem
test
sensit
specif
fip
spark
et
al
state
diagnosi
fip
depend
presenc
multipl
abnorm
compat
diseas
increas
specif
recent
recombin
felin
interferon
rfeifn
market
japan
uk
ec
countri
felin
japanes
market
canin
european
market
viral
infect
label
indic
martin
et
al
sakurai
et
al
ueda
et
al
although
signific
antivir
effect
rfeifn
felin
coronavirus
demonstr
vitro
mochizuki
et
al
immunomodulatori
effect
interferon
gener
accept
tompkin
might
use
treatment
immunolog
diseas
fip
clinic
diagnosi
fip
establish
cat
present
hospit
case
includ
six
male
six
femal
age
vari
month
year
criteria
diagnosi
includ
antibiot
nonrespons
chronic
fever
low
normal
pcv
valu
mild
nonregen
anemia
pcv
normal
rang
hyperglobulinemia
electrophoret
evid
polyclon
gammopathi
nonsept
inflammatori
ascitespleur
effus
effus
characterist
find
cytolog
patholog
evid
pyogranuloma
drytyp
fcov
serum
antibodi
titer
immunoperoxidas
method
use
infect
cell
antigen
mandatori
find
effus
evid
bacteri
infect
high
specif
graviti
sg
high
protein
content
tp
gdl
low
albuminglobulin
ratio
ag
low
cellular
cell
microlit
mix
cell
reaction
nondegener
neutrophil
lymphocyt
macrophag
spark
et
al
diagnosi
fip
establish
cat
either
characterist
effus
needl
biopsyconfirm
granuloma
find
patient
stabil
gener
support
therapi
includ
thoracocenthesi
oxygen
administr
fluid
therapi
medic
treatment
initi
treatment
regimen
rfeifn
initi
administ
subcutan
mukg
everi
day
remiss
follow
weekli
subcutan
inject
dosag
glucocorticoid
use
either
intrathorac
inject
dexamethason
mgkg
case
respiratori
emerg
follow
oral
dose
prednisolon
mgkg
daili
gradual
taper
mgkg
everi
day
oral
prednisolon
start
tabl
show
summari
case
studi
outcom
case
spay
femal
domest
shorthair
dsh
cat
present
difficulti
breath
fever
diagnos
thorac
effus
form
fip
fcov
antibodi
titer
margin
low
normal
pcv
elev
serum
total
protein
gdl
mark
polyclon
gammopathi
rfeifn
mukg
everi
day
prednisolon
mgkg
po
bid
pleural
effus
disappear
week
mainten
therapi
weekli
dose
rfeifn
prednisolon
mgkg
po
everi
day
cat
healthi
month
diagnosi
treatment
termin
fcov
antibodi
cat
still
healthi
end
observ
period
case
femal
persian
cat
year
month
age
present
fever
abdomin
distens
cat
fcov
antibodi
titer
elev
total
serum
protein
gdl
polyclon
gammopathi
margin
low
pcv
proteinuria
induct
therapi
rfeifn
mukg
sc
everi
day
prednisolon
mgkg
po
bid
ascit
decreas
month
complet
disappear
month
mainten
therapi
weekli
dose
rfeifn
mukg
continu
year
diagnosi
prednisolon
given
year
fcov
antibodi
titer
cat
healthi
case
male
dsh
cat
year
month
age
present
difficulti
breath
anemia
fever
thoracocenthesi
reveal
characterist
nonsept
effus
gdl
serum
fcov
antibodi
titer
total
protein
elev
gdl
polyclon
gammopathi
induct
therapi
rfeifn
mukg
sc
everi
day
alon
effect
complet
remov
effus
fever
day
treatment
termin
day
mainten
therapi
cat
owner
financi
concern
cat
reportedli
healthi
year
diagnosi
case
castrat
male
dsh
cat
fever
pleural
effus
gdl
anemia
although
serum
total
protein
significantli
elev
gdl
mark
polyclon
gammopathi
note
serum
fcov
antibodi
titer
thoracocenthesi
intrathorac
inject
mgkg
dexamethason
given
rfeifn
start
mukg
sc
everi
day
daili
oral
prednisolon
mgkg
pleural
effus
disappear
week
mainten
therapi
weekli
rfeifn
daili
oral
prednisolon
mgkg
start
prednisolon
taper
mgkg
po
everi
day
treatment
stop
month
serum
fcov
antibodi
titer
cat
healthi
year
diagnosi
partial
remiss
includ
one
drytyp
three
effus
form
fip
case
rel
young
age
surviv
time
month
month
four
case
show
respons
therapi
die
within
month
overal
efficaci
studi
complet
respons
remiss
year
partial
respons
remiss
month
sinc
surviv
year
older
cat
year
older
diseas
progress
older
cat
may
slower
immunolog
pathogenesi
may
differ
cat
rfeifn
therapi
may
possibl
impact
diseas
sinc
glucocorticoid
therapi
proven
effect
induc
complet
remiss
fip
mcreynold
maci
present
result
may
demonstr
appar
therapeut
effect
rfeifn
case
possibl
critic
present
studi
includ
experiment
design
match
case
control
control
studi
confirm
fip
case
warrant
prove
efficaci
rfeifn
therapi
although
accuraci
clinic
diagnosi
present
studi
part
confirm
necropsi
dead
case
way
confirm
diagnosi
surviv
therefor
futur
studi
immunofluoresc
detect
fcov
antigen
mononuclear
cell
effus
use
monoclon
antibodi
may
good
altern
invas
biopsi
also
specif
sensit
pcr
detect
fcov
genom
effus
establish
concurr
use
glucocorticoid
seem
interfer
effect
interferon
case
surviv
immunomodulatori
effect
interferon
involv
enhanc
antivir
immunolog
event
compat
immunosuppress
effect
respons
glucocorticoid
interferon
exert
effect
modul
immunolog
inflammatori
process
interest
studi
optim
dose
schedul
glucocorticoid
